Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms

Magdalena Czader, Attilio Orazi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

OBJECTIVES: This session of the Society for Hematopathology/European Association for Haematopathology workshop focused on disease progression in myeloproliferative neoplasms (MPNs).

METHODS: The session included typical and unusual presentations of chronic myelogenous leukemia (CML), BCR-ABL1 positive; Philadelphia chromosome-negative (Ph-neg) MPNs; and mastocytosis.

RESULTS: Cases of CML illustrated various manifestations of progression, with emphasis on criteria defining stages of the disease. Issues were discussed related to the patterns of recurrence in patients receiving tyrosine kinase inhibitor therapy, including leukemic transformation occurring in a Ph-neg clone. Ph-neg MPN cases highlighted diagnostic approaches used to establish accelerated and blast phases, including cases with significant myelofibrosis and when an adequate bone marrow aspirate smear is not available. The session also included rare cases of aggressive mastocytosis.

CONCLUSIONS: There was agreement that a definitive diagnosis can be challenging in the absence of documented review of prior diagnostic material and clinical history.

Original languageEnglish
Pages (from-to)188-206
Number of pages19
JournalAmerican Journal of Clinical Pathology
Volume144
Issue number2
DOIs
StatePublished - Aug 1 2015

Fingerprint

Philadelphia Chromosome
Acute Myeloid Leukemia
Mastocytosis
Disease Progression
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Blast Crisis
Neoplasms
Primary Myelofibrosis
Protein-Tyrosine Kinases
Clone Cells
Bone Marrow
Education
Recurrence
Therapeutics

Keywords

  • Accelerated phase
  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • BCR-ABL1 positive
  • Blast phase
  • Chronic myelogenous leukemia
  • Chronic neutrophilic leukemia
  • Essential thrombocythemia
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
  • Polycythemia vera
  • Primary myelofibrosis
  • Progression
  • Systemic mastocytosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms. / Czader, Magdalena; Orazi, Attilio.

In: American Journal of Clinical Pathology, Vol. 144, No. 2, 01.08.2015, p. 188-206.

Research output: Contribution to journalArticle

@article{aee44068f53043ddb9e0a4f778db501e,
title = "Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms",
abstract = "OBJECTIVES: This session of the Society for Hematopathology/European Association for Haematopathology workshop focused on disease progression in myeloproliferative neoplasms (MPNs).METHODS: The session included typical and unusual presentations of chronic myelogenous leukemia (CML), BCR-ABL1 positive; Philadelphia chromosome-negative (Ph-neg) MPNs; and mastocytosis.RESULTS: Cases of CML illustrated various manifestations of progression, with emphasis on criteria defining stages of the disease. Issues were discussed related to the patterns of recurrence in patients receiving tyrosine kinase inhibitor therapy, including leukemic transformation occurring in a Ph-neg clone. Ph-neg MPN cases highlighted diagnostic approaches used to establish accelerated and blast phases, including cases with significant myelofibrosis and when an adequate bone marrow aspirate smear is not available. The session also included rare cases of aggressive mastocytosis.CONCLUSIONS: There was agreement that a definitive diagnosis can be challenging in the absence of documented review of prior diagnostic material and clinical history.",
keywords = "Accelerated phase, Acute lymphoblastic leukemia, Acute myeloid leukemia, BCR-ABL1 positive, Blast phase, Chronic myelogenous leukemia, Chronic neutrophilic leukemia, Essential thrombocythemia, Myelodysplastic syndromes, Myeloproliferative neoplasms, Polycythemia vera, Primary myelofibrosis, Progression, Systemic mastocytosis",
author = "Magdalena Czader and Attilio Orazi",
year = "2015",
month = "8",
day = "1",
doi = "10.1309/AJCPZQK40JOZZZCC",
language = "English",
volume = "144",
pages = "188--206",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms

AU - Czader, Magdalena

AU - Orazi, Attilio

PY - 2015/8/1

Y1 - 2015/8/1

N2 - OBJECTIVES: This session of the Society for Hematopathology/European Association for Haematopathology workshop focused on disease progression in myeloproliferative neoplasms (MPNs).METHODS: The session included typical and unusual presentations of chronic myelogenous leukemia (CML), BCR-ABL1 positive; Philadelphia chromosome-negative (Ph-neg) MPNs; and mastocytosis.RESULTS: Cases of CML illustrated various manifestations of progression, with emphasis on criteria defining stages of the disease. Issues were discussed related to the patterns of recurrence in patients receiving tyrosine kinase inhibitor therapy, including leukemic transformation occurring in a Ph-neg clone. Ph-neg MPN cases highlighted diagnostic approaches used to establish accelerated and blast phases, including cases with significant myelofibrosis and when an adequate bone marrow aspirate smear is not available. The session also included rare cases of aggressive mastocytosis.CONCLUSIONS: There was agreement that a definitive diagnosis can be challenging in the absence of documented review of prior diagnostic material and clinical history.

AB - OBJECTIVES: This session of the Society for Hematopathology/European Association for Haematopathology workshop focused on disease progression in myeloproliferative neoplasms (MPNs).METHODS: The session included typical and unusual presentations of chronic myelogenous leukemia (CML), BCR-ABL1 positive; Philadelphia chromosome-negative (Ph-neg) MPNs; and mastocytosis.RESULTS: Cases of CML illustrated various manifestations of progression, with emphasis on criteria defining stages of the disease. Issues were discussed related to the patterns of recurrence in patients receiving tyrosine kinase inhibitor therapy, including leukemic transformation occurring in a Ph-neg clone. Ph-neg MPN cases highlighted diagnostic approaches used to establish accelerated and blast phases, including cases with significant myelofibrosis and when an adequate bone marrow aspirate smear is not available. The session also included rare cases of aggressive mastocytosis.CONCLUSIONS: There was agreement that a definitive diagnosis can be challenging in the absence of documented review of prior diagnostic material and clinical history.

KW - Accelerated phase

KW - Acute lymphoblastic leukemia

KW - Acute myeloid leukemia

KW - BCR-ABL1 positive

KW - Blast phase

KW - Chronic myelogenous leukemia

KW - Chronic neutrophilic leukemia

KW - Essential thrombocythemia

KW - Myelodysplastic syndromes

KW - Myeloproliferative neoplasms

KW - Polycythemia vera

KW - Primary myelofibrosis

KW - Progression

KW - Systemic mastocytosis

UR - http://www.scopus.com/inward/record.url?scp=84942570892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942570892&partnerID=8YFLogxK

U2 - 10.1309/AJCPZQK40JOZZZCC

DO - 10.1309/AJCPZQK40JOZZZCC

M3 - Article

VL - 144

SP - 188

EP - 206

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -